In conclusion, baseline elevations in C2 and Factor B indicate upregulation of the complement pathway in T2D and changes in complement pathway-related protein levels in response to hypoglycemia suggest both intrinsic and alternative pathway activation at 2-h that appear driven by the underlying inflammation in T2D and that could contribute to a cardiovascular event. The gene discussed is C2; the disease is Hypoglycemia.